Current use of HER2 tests

Author： Schaller G.   Evers K.   Papadopoulos S.   Ebert A.   Bühler H.  

Publisher： Springer Publishing Company

ISSN： 0923-7534

Source： Annals of Oncology, Vol.12, Iss.12, 2001-12, pp. : 97-100

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HER2-Positive Breast Cancer: Current Treatment Strategies

By Perez Edith   Baweja Mansoina  

Cancer Investigation, Vol. 26, Iss. 6, 2008-07 ,pp. : 545-552

Informa Healthcare

Access to resources Recommend Favorite

Treatment of brain metastases from HER-2-positive breast cancer: current status and new concepts

By Bartolotti Marco   Franceschi Enrico   Brandes Alba A  

Future Oncology, Vol. 9, Iss. 11, 2013-11 ,pp. : 1653-1664

Future Medicine

Access to resources Recommend Favorite

High recurrence risk and use of adjuvant trastuzumab in patients with small, HER2-positive, node-negative breast cancers

By Horio Akiyo  

International Journal of Clinical Oncology, Vol. 17, Iss. 2, 2012-04 ,pp. : 131-136

Springer Publishing Company

Access to resources Recommend Favorite

HER2 - a 'predictive factor' ready to use in the daily management of breast cancer patients?

By Piccart M.J.   Di Leo A.   Hamilton A.  

European Journal of Cancer, Vol. 36, Iss. 14, 2000-09 ,pp. : 1755-1761

Elsevier

Access to resources Recommend Favorite

Continued Use of Trastuzumab (Herceptin) after Progression on Prior Trastuzumab Therapy in HER-2-Positive Metastatic Breast Cancer

By Pusztai Lajos   Esteva Francisco  

Cancer Investigation, Vol. 24, Iss. 2, 2006-05 ,pp. : 187-191

Informa Healthcare

Access to resources Recommend Favorite